Xcelience.com

Since 2008, Derek Hennecke has been a featured columnist in Drug Development & Delivery (formerly known as Drug Delivery Technology) .   We have received so much praise and interest for these columns that we decided to feature them on this dedicated page. 

2011 Series: How Not To Blow the Recovery

• Part 3 – When Deals Work & When They Don’t; Large Pharma Strategies for Off-Loading Shuttered Capacity

• Part 2 – Drug Pricing 101

• Part 1 – Lessons Learned from Genzyme, Johnson & Johnson, and Baxter

2010 Series: Business Models & Best Practices for Navigating the New Normal

• Part 6 – Pharma’s Innovation Crisis: How Can Our Industry Save Itself?

• Part 5 – Tradeshows: Why We Love (Hate) Them

• Part 4 – Looking for Gorillas

• Part 3 – How to Choose a CRO

• Part 2 – United We Stand; the Power of Alliances in the New Normal

• Part 1 – Industry Layoffs: Recessionary Medicine That’s Worse Than The Disease

2009 Series: Unique Strategies for Building Lasting Competitive Advantage

• Part 6 – The Fight Within Pharma

• Part 5 – The New World: Life After the Great Recession

• Part 4 – David vs. Goliath: Why The Little Guys Have All The Advantages

• Part 3 – The Superhero Complex

• Part 2 – API Characterization Services – Does Your Molecule Need Tutoring?

• Part 1 – Growth or Recession: Selling Solutions Is The Answer

2008 Series: Challenges, Issues and Opportunities In The Xcelience Management Buy-Out

• Part 7 – The Deal

• Part 6 – Living The Dream!

• Part 5 – The Big Three – Employees, Managers, Customers

• Part 4 – Personal Guarantees:  The Bad & The Evil

• Part 3 – Financing The Purchase:  Where Will It Come From?

• Part 2 – The Management Buy-Out:  What’s a Fair Price? 

• Part 1 – The Born Again Entrepreneur